Emergency Neurological Life Support: Status Epilepticus

Neurocritical Care

Volumn 23, Issue , 2015, Pages 136-142

  Claassen, Jan ^a   Riviello, James J ^a   Silbergleit, Robert ^b  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Anticonvulsant; EEG monitoring; Pharmacologic coma; Protocol; Seizures; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE; DIAZEPAM; ETIRACETAM; FOSPHENYTOIN SODIUM; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PYRIDOXINE; VALPROIC ACID;

CHILD HEALTH CARE; CLINICAL ASSESSMENT TOOL; CLINICAL HANDOVER; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG CONTRAINDICATION; DRUG EFFICACY; ELECTROCARDIOGRAM; ELECTROENCEPHALOGRAM; EMERGENCY CARE; EMERGENCY HEALTH SERVICE; EMERGENCY NEUROLOGICAL LIFE SUPPORT; EPILEPTIC STATE; FLUID RESUSCITATION; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE; LABORATORY TEST; LIVER TOXICITY; LOADING DRUG DOSE; MEDICAL HISTORY; MEDICATION COMPLIANCE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROMONITORING; OXYGEN THERAPY; PRIORITY JOURNAL; PROPOFOL INFUSION SYNDROME; PYRIDOXINE DEFICIENCY; RECURRENT DISEASE; REPEATED DRUG DOSE; RESUSCITATION; REVIEW; SEIZURE; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; TIME TO TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; EMERGENCY TREATMENT; LONG TERM CARE; NEUROLOGY; PROCEDURES; STATUS EPILEPTICUS;

EMERGENCY TREATMENT; HUMANS; LIFE SUPPORT CARE; NEUROLOGY; STATUS EPILEPTICUS;

EID: 84947127101     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-015-0172-3     Document Type: Review

References (32)

1. Pallin DJ, Goldstein JN, Moussally JS, Pelletier AJ, Green AR, Camargo CA Jr. Seizure visits in US emergency departments: epidemiology and potential disparities in care. Int J Emerg Med. 2008;1:97–105.
2. Farhidvash F, Singh P, Abou-Khalil B, Arain A. Patients visiting the emergency room for seizures: insurance status and clinic follow-up. Seizure. 2009;18:644–7.
3. Pitts SR, Niska RW, Xu J, National Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2006;2008:1–38.
4. Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998;339:792–8.
5. Logroscino G, Hesdorffer DC, Cascino G, Annegers JF, Hauser WA. Short-term mortality after a first episode of status epilepticus. Epilepsia. 1997;38:1344–9.
6. Towne AR, Pellock JM, Ko D, DeLorenzo RJ. Determinants of mortality in status epilepticus. Epilepsia. 1994;35:27–34.
7. Legriel S, Mourvillier B, Bele N, et al. Outcomes in 140 critically ill patients with status epilepticus. Intensive Care Med. 2008;34:476–80.
8. Legriel S, Azoulay E, Resche-Rigon M, et al. Functional outcome after convulsive status epilepticus. Crit Care Med. 2010;38:2295–303.
9. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med. 2001;345:631–7.
10. Scholtes FB, Renier WO, Meinardi H. Generalized convulsive status epilepticus: causes, therapy, and outcome in 346 patients. Epilepsia. 1994;35:1104–12.
11. Claassen J, Hirsch LJ, Emerson RG, Bates JE, Thompson TB, Mayer SA. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus. Neurology. 2001;57:1036–42.
12. Rossetti AO, Hurwitz S, Logroscino G, Bromfield EB. Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation. J Neurol Neurosurg Psychiatry. 2006;77:611–5.
13. Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2 + sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17:7532–40.
14. Morimoto K, Fahnestock M, Racine RJ. Kindling and status epilepticus models of epilepsy: rewiring the brain. Prog Neurobiol. 2004;73:1–60.
15. Ravizza T, Vezzani A. Status epilepticus induces time-dependent neuronal and astrocytic expression of interleukin-1 receptor type I in the rat limbic system. Neuroscience. 2006;137:301–8.
16. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40:S3–8.
17. Lowenstein DH, Alldredge BK. Status epilepticus. N Engl J Med. 1998;338:970–6.
18. Silbergleit R, Durkalski V, Lowenstein DH, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012;366:591–600.
19. DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia. 1998;39:833–40.
20. Lowenstein DH, Alldredge BK. Status epilepticus at an urban public hospital in the 1980s. Neurology. 1993;43:483–8.
21. Agarwal P, Kumar N, Chandra R, Gupta G, Antony AR, Garg N. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16:527–32.
22. Shaner DM, McCurdy SA, Herring MO, Gabor AJ. Treatment of status epilepticus: a prospective comparison of diazepam and phenytoin versus phenobarbital and optional phenytoin. Neurology. 1988;38:202–7.
23. Misra UK, Kalita J, Patel R. Sodium valproate vs phenytoin in status epilepticus: a pilot study. Neurology. 2006;67:340–2.
24. Berning S, Boesebeck F, van Baalen A, Kellinghaus C. Intravenous levetiracetam as treatment for status epilepticus. J Neurol. 2009;256:1634–42.
25. Claassen J, Hirsch LJ, Emerson RG, Mayer SA. Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review. Epilepsia. 2002;43:146–53.
26. Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011;10:922–30.
27. Rossetti AO, Milligan TA, Vulliemoz S, Michaelides C, Bertschi M, Lee JW. A randomized trial for the treatment of refractory status epilepticus. Neurocrit Care. 2011;14:4–10.
28. Iyer VN, Hoel R, Rabinstein AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med. 2009;37:3024–30.
29. Limdi NA, Shimpi AV, Faught E, Gomez CR, Burneo JG. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. 2005;64:353–5.
30. Sinha S, Naritoku DK. Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology. 2000;55:722–4.
31. Tripathi M, Vibha D, Choudhary N, et al. Management of refractory status epilepticus at a tertiary care centre in a developing country. Seizure. 2010;19:109–11.
32. Brophy GM, Bell R, Claassen J, Alldredge B, Bleck TP, Glauser T, Laroche SM, Riviello JJ Jr, Shutter L, Sperling MR, Treiman DM, Vespa PM, Neurocritical Care Society Status Epilepticus Guideline Writing Committee. Guidelines for the Evaluation and Management of Status Epilepticus. Neurocrit Care. 2012;17:3–23.